Skip to content

All recalls FDA

FDADrugsRecalled Status: Closed by the agency

EPI Health, LLC recalls minolira (minocycline hydrochloride) extended-release tablets

Class IIofficial

FDA Class II

FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.

Hazard
CGMP Deviation: Discontinuation of the Quality program by manufacturer that would assure product meet the identity, strength, quality, and purity characteristics that they are purported or represented to possess.
Products
  • minolira (minocycline hydrochloride) extended-release tablets
Where it was sold

US Nationwide

Nationwide

Units affected
5664 bottles
About this recall
minolira (minocycline hydrochloride) extended-release tablets, 135mg 30-count Bottle, Rx Only, Mfg by: Dr Reddy's Laboratories Limited, INDIA, Manufactured for: EPI Health, LLC, Charleston, SC 29403, NDC 71403-102-30.